(Q85046829)

English

CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by up-regulation of Foxp3+ regulatory T cells in the target tissue: kidney

scientific article published on 17 September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850528%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by up-regulation of Foxp3+ regulatory T cells in the target tissue: kidney (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850528%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

lupus nephritis

1 reference

based on heuristic

inferred from title

author name string

Ji-Lu Zhang

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850528%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

De-Jun Sun

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850528%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Chun-Mei Hou

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850528%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Ying-Lin Wei

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850528%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Xin-Ying Li

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850528%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Zu-Yin Yu

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850528%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Jian-Nan Feng

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850528%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Bei-Fen Shen

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850528%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Yan Li

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850528%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

He Xiao

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850528%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

17 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850528%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Transplant Immunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850528%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850528%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850528%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

17-25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850528%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

The induction of organ-specific antibodies during the graft-vs.-host reaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

New approaches for preventing and treating chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Identification of a monoclonal antibody specific for a murine T3 polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on T(h)1 cells that is augmented by IL-4

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Treatment with nonmitogenic anti-CD3 monoclonal antibody induces CD4+ T cell unresponsiveness and functional reversal of established experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

CD3-specific antibodies: a portal to the treatment of autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Reversal of naturally occuring diabetes in primates by unmodified islet xenografts without chronic immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Graft-Versus-Host Disease: Pathophysiological and Clinical Aspects

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Outcomes of recipients of both bone marrow and solid organ transplants. A review.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Genetic factors influencing the development of chronic graft-versus-host disease in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.-host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Antagonist of secondary lymphoid-tissue chemokine (CCR ligand 21) prevents the development of chronic graft-versus-host disease in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Induction and effector functions of T(H)17 cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

T(H)-17 cells in the circle of immunity and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

The role of IL-23/IL-17 axis in lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Suppression of murine SLE by oral anti-CD3: inducible CD4+CD25-LAP+ regulatory T cells control the expansion of IL-17+ follicular helper T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.09.002

7 January 2021

Identifiers

10.1016/J.TRIM.2010.09.002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850528%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20850528%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85046829&oldid=1689771158"